Healthcare


 Race Oncology Expands RC220 Trial in Hong Kong with Focus on Advanced Solid Tumours

Race Oncology Expands RC220 Trial in Hong Kong with Focus on Advanced Solid Tumours

September 02, 2025 11:01 AM AEST| By Team Kalkine Media

Race Oncology (ASX:RAC) advances its RC220 trial with the first Hong Kong site activation, strengthening its clinical research efforts in advanced solid tumours.

 Santos (ASX:STO) takeover sparks ASX 200 volatility amid state scrutiny

Santos (ASX:STO) takeover sparks ASX 200 volatility amid state scrutiny

September 01, 2025 04:49 PM AEST| By Team Kalkine Media

Highlights,South Australian government to evaluate the Abu Dhabi-led acquisition of Santos,Ministerial approval required for change in controlling interest for licence holders,Share price movement reflects heightened investor attention on Santos' ope...

 Is ASX:MX1 financially exposed? Micro-X debt scrutiny raises questions ASX 300

Is ASX:MX1 financially exposed? Micro-X debt scrutiny raises questions ASX 300

September 01, 2025 04:19 PM AEST| By Team Kalkine Media

Highlights:,Micro-X (ASX:MX1), listed on the,ASX 300,, has taken on debt after previously holding none.,The company’s liabilities exceed its combined short-term cash and receivables.,Revenue contraction and cash outflows mark challenges ahead for the...

 How Alterity Therapeutics (ASX:ATH) Is Managing Growth Amid Cash Flow Questions ASX 300

How Alterity Therapeutics (ASX:ATH) Is Managing Growth Amid Cash Flow Questions ASX 300

September 01, 2025 04:05 PM AEST| By Team Kalkine Media

Highlights,Alterity Therapeutics (ASX:ATH) operates in the biotechnology sector, currently listed on the,ASX 300,index.,The company has reported a decrease in cash burn over the past year, signaling operational discipline.,Despite being pre-revenue,...

 Insider Buying in ReNerve (ASX:RNV) Faces Value Strain Despite Ownership Confidence All Ordinaries

Insider Buying in ReNerve (ASX:RNV) Faces Value Strain Despite Ownership Confidence All Ordinaries

September 01, 2025 03:29 PM AEST| By Team Kalkine Media

Highlights,Insider share purchases in ReNerve have not recovered from their original costs despite recent price movements,The company’s Independent Chairman previously acquired shares at significantly higher levels,ReNerve insiders hold a considerabl...

 Is Micro-X (ASX:MX1) Carrying Too Much Financial Strain?

Is Micro-X (ASX:MX1) Carrying Too Much Financial Strain?

September 01, 2025 02:59 PM AEST| By Team Kalkine Media

Micro-X (ASX:MX1) reported short-term liabilities exceeding cash reserves and receivables Company continues to operate with a net debt balance and negative EBIT performance Revenues have declined while the business faces balance sheet pressures

 4D Medical (ASX:4DX) Soars After FDA Nod for Lung Imaging Tool All Ordinaries

4D Medical (ASX:4DX) Soars After FDA Nod for Lung Imaging Tool All Ordinaries

September 01, 2025 02:14 PM AEST| By Team Kalkine Media

Highlights,4D Medical secures US FDA clearance for CT-based lung imaging device,The CT:VQ system offers a non-invasive diagnostic approach without contrast agents,Pro Medicus and Lumos Diagnostics also advance healthcare tech initiatives in the US,4D...

 Amplia Therapeutics Lists New Securities on ASX ATX Strengthens Biotech Strategy

Amplia Therapeutics Lists New Securities on ASX ATX Strengthens Biotech Strategy

September 01, 2025 02:13 PM AEST| By Team Kalkine Media

Highlights,Amplia Therapeutics quotes additional fully paid ordinary securities on the ASX,The move is linked to a previously disclosed transaction to support company operations,Amplia focuses on drug development for cancer and fibrotic diseases,Ampl...

 4DMedical (ASX:4DX) Wins FDA Clearance for CT:VQ Imaging, Opening New Pathways in Respiratory Care

4DMedical (ASX:4DX) Wins FDA Clearance for CT:VQ Imaging, Opening New Pathways in Respiratory Care

September 01, 2025 12:09 PM AEST| By Team Kalkine Media

4DMedical (ASX:4DX) secures FDA clearance for CT:VQ imaging software, revolutionising lung diagnostics with advanced technology and expanding access across healthcare systems.

 Inside Sigma Healthcare’s Ownership Structure Amid Insider Movements ASX 300

Inside Sigma Healthcare’s Ownership Structure Amid Insider Movements ASX 300

August 29, 2025 08:02 PM AEST| By Team Kalkine Media

Sigma Healthcare (ASX:SIG) displays significant insider ownership, with key executives holding substantial stakes A small number of shareholders collectively hold a majority interest in the company Despite recent insider sales, Sigma Healthcare...

 ASX 200 index Dividend Timing And Coverage Factors For Sonic Healthcare

ASX 200 index Dividend Timing And Coverage Factors For Sonic Healthcare

August 29, 2025 06:16 PM AEST| By Team Kalkine Media

A concise review of Sonic Healthcare Limited (ASX:SHL) evaluates upcoming distribution timing, payout coverage, and operational context within the broader market, focusing on sustainability signals, historical patterns, and sector dynamics

 Paragon Care’s (ASX:PGC) Share Valuation Reflects Growth Confidence ASX 300

Paragon Care’s (ASX:PGC) Share Valuation Reflects Growth Confidence ASX 300

August 29, 2025 04:13 PM AEST| By Team Kalkine Media

Highlights,Paragon Care (ASX:PGC) shows elevated valuation against broader Australian peers,Earnings trajectory aligns with optimism around future business expansion,Broader ASX 300 market benchmarks provide contrast to sector-specific pricing,Parago...

 Australian Clinical Labs (ASX:ACL) Dividend News Lifts Market Attention ASX 300

Australian Clinical Labs (ASX:ACL) Dividend News Lifts Market Attention ASX 300

August 29, 2025 03:52 PM AEST| By Team Kalkine Media

Highlights,Australian Clinical Labs (ASX:ACL) approaches ex-dividend date for upcoming payout,Shareholders must be recorded before the deadline to receive the announced dividend,Payout aligns with previous distributions supported by company earnings...

 ASX200 Healthcare Stocks Struggle Amid Reporting Season Swings

ASX200 Healthcare Stocks Struggle Amid Reporting Season Swings

August 29, 2025 03:13 PM AEST| By Team Kalkine Media

Highlights,ASX healthcare sector declines amid turbulent reporting season,CSL (ASX:CSL) and Ramsay (ASX:RHC) weigh heavily on sector performance,Sigma (ASX:SIG) gains traction post Chemist Warehouse merger,The,ASX 200,healthcare sector experienced sh...

 Why this ASX Share Remains a Strong Focus Among ASX 200 Companies

Why this ASX Share Remains a Strong Focus Among ASX 200 Companies

August 29, 2025 12:08 PM AEST| By Team Kalkine Media

Highlights,CSL (CSL) operates as a global leader in biotechnology.,Healthcare sector provides resilient and consistent revenue streams.,Growing ethical investment trends support long-term appeal.,CSL in the Spotlight,CSL Ltd (ASX:CSL) has long been r...

 ASX 300 Today Neuren Pharmaceuticals (ASX:NEU) Shows Promising Market Engagement

ASX 300 Today Neuren Pharmaceuticals (ASX:NEU) Shows Promising Market Engagement

August 28, 2025 08:57 PM AEST| By Team Kalkine Media

Highlights,Neuren Pharmaceuticals demonstrates ongoing growth in earnings and revenue.,Insider participation reflects strong alignment with company performance.,Operational efficiency and strategic focus support sustainable market presence.,The,ASX 3...

 ImExHS (ASX:IME) insiders raise stakes but face market pressure ASX 300

ImExHS (ASX:IME) insiders raise stakes but face market pressure ASX 300

August 28, 2025 03:41 PM AEST| By Team Kalkine Media

Highlights,ImExHS insiders made multiple share purchases across the past year,A notable insider increased their stake at a price above current levels,Insiders collectively hold a significant portion of the company’s shares,ImExHS Limited (ASX:IME), a...

 Care Economy Stocks Powering ASX 200's Tech-Led Future

Care Economy Stocks Powering ASX 200's Tech-Led Future

August 28, 2025 02:57 PM AEST| By Team Kalkine Media

Highlights,Control Bionics (ASX:CBL), InteliCare (ASX:ICR), and Talius Group (ASX:TAL) are developing advanced technologies supporting aged and disability care.,Government initiatives like the Care Economy CRC aim to integrate data, technology, and w...

 Telix Pharmaceuticals Faces FDA Setback ASX 200 Biotech Update

Telix Pharmaceuticals Faces FDA Setback ASX 200 Biotech Update

August 28, 2025 02:54 PM AEST| By Team Kalkine Media

Highlights,Telix Pharmaceuticals receives a Complete Response Letter from the FDA,Concerns focused on third-party manufacturing processes, not product efficacy,Company to address regulatory standards before resubmitting,Telix Pharmaceuticals Ltd (ASX...

 Ramsay Health Care (ASX:RHC) Faces Profit Challenges While Remaining in ASX 200 Spotlight

Ramsay Health Care (ASX:RHC) Faces Profit Challenges While Remaining in ASX 200 Spotlight

August 28, 2025 01:27 PM AEST| By Team Kalkine Media

Highlights,Ramsay Health Care (RHC) faces decline in profit results,Impact from one-off impairments weighs on overall performance,Outlook signals growth in operations despite financial pressures,Ramsay Health Care (ASX:RHC), one of the well-known,ASX...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.